Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00747591 · ClinicalTrials.gov registry record
Urine Concentration of S100B in Extremely Premature Infants
A clinical trial, sponsored by University of Utah.
- Completed
- Registry status
- 68
- Enrollment target
NCT00747591: Completed study, sponsored by University of Utah.
NCT00747591 is a clinical trial that has completed, run by University of Utah. The registered enrollment target is 68 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00747591 has completed, sponsored by University of Utah.
- COMPLETED
- Registry status
- 68 participants
- Enrollment target
Study Summary
S100B, a calcium-binding protein, is found predominantly in the central nervous system (CNS) and is increased in CSF and blood after CNS injury. There are two objectives to this study. Is urine S100B concentration correlated with the serum concentration of S100B in infants born at 29-36 weeks gestation. The presence and severity of intracranial pathology on S100B concentration will be investigated. Further analysis will demonstrate if birth weight, daily fluid intake, urine output, and urine creatinine influence this relationship.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 68 participants |
| Start Date | 2002-11 |
| Est. Completion | 2005-04 |
What the finished NCT00747591 record still lists
NCT00747591 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 68 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00747591 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00747591 about?
NCT00747591 is a clinical study titled "Urine Concentration of S100B in Extremely Premature Infants". S100B, a calcium-binding protein, is found predominantly in the central nervous system (CNS) and is increased in CSF and blood after CNS injury. There are two objectives to this study. Is urine S100B concentration correlated with the serum concentration of S100B in infants born at 29-36 weeks gestat...
What is the current status of trial NCT00747591?
This trial is currently completed. The enrollment target is 68 participants. The study started on 2002-11. Estimated completion is 2005-04.
Who is sponsoring clinical trial NCT00747591?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02044497 · 68 participants · Phase 4
Population Pharmacokinetics and Pharmacogenomics of Oral Oxycodone in Pediatric Surgical Patients
- NCT03779854 · 68 participants · Phase 2
Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant
- NCT03821246 · 68 participants · Phase 2
Neoadjuvant Atezolizumab-Based Combination Therapy in Men With Localized Prostate Cancer Prior to Radical Prostatectomy
- NCT04115514 · 68 participants · Phase 2
Treatment of ARDS With Instilled T3
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia